Quest Diagnostics, Inc.

Quest Diagnostics, Inc.

DGX

Market Cap$20.12B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Quest Diagnostics, Inc.Quest Diagnostics, Inc.22.31.69%19%20.9

Earnings Call Q1 2025

April 22, 2025 - AI Summary

Strong Revenue Growth: Quest Diagnostics reported a 12.1% increase in consolidated revenues for the first quarter of 2025, totaling $2.65 billion. Organic revenue growth was 2.4%, mainly attributed to acquisitions and demand recovery in the advanced diagnostics portfolio. They reaffirmed guidance for full-year revenues to be between $10.7 billion and $10.85 billion.
Positive Adjusted EPS: Reported diluted EPS rose to $1.94 from $1.72 YOY, while adjusted EPS increased to $2.21 from $2.04 in the previous year. The guidance for adjusted EPS for the full year remains unchanged at $9.55 to $9.80, indicating stable profitability despite inflation pressures and higher interest expenses.
Challenges from Weather and Volume: Despite revenue growth, total organic volume declined by 0.9%, affected by weather-related disruptions and one less operating day compared to the previous year. However, there was a notable bounce back in volume during March, leading to a more optimistic outlook for the upcoming months.

Exclusive for Stockcircle Pro members

Sign upSign Up
$195.00

Target Price by Analysts

9% upsideQuest Diagnostics Target Price DetailsTarget Price
$270.73

Current Fair Value

51.3% upside

Undervalued by 51.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$20.12 Billion
Enterprise Value$26.50 Billion
Dividend Yield$3.05 (1.69246989623217%)
Earnings per Share$7.8
Beta0.49
Outstanding Shares111,000,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio22.3
PEG166.39
Price to Sales1.97
Price to Book Ratio2.89
Enterprise Value to Revenue2.61
Enterprise Value to EBIT26.39
Enterprise Value to Net Income20
Total Debt to Enterprise0.25
Debt to Equity0.95

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Quest Diagnostics, Inc.

47,000 employees
CEO: Stephen Rusckowski

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy beh...